AVENUE SOLUTIONS for GENENTECH USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Senate Finance Committee Drug Pricing Reform Principles; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
Medicare/Medicaid MMM
Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Senate Finance Committee Drug Pricing Reform Principles; Proposed repeal of the CMS Rule on Most Favored Nation Model; Delay of the Rebate Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.